Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Kim D, Sundling KE, Virk R, Thrall MJ, Alperstein S, Bui MM, et al. Digital cytology part 1: digital cytology implementation for practice: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol. 2024;13(2):86-96.

Gal J, Mosquera JM, Robinson BD, Schlegel PN. Incidental seminoma in nonobstructive azoospermia: a case report. F S Rep. 2024;5(2):211-213.

Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, et al. Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2024;630(8016):E7.

Caplan AS, Todd GC, Zhu YC, Sikora M, Akoh CC, Jakus J, et al. Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae. JAMA Dermatol. 2024;160(7):701-709.

Bidot S, Yin J, Zhou P, Zhang L, Deeb KK, Smith G, et al. Genetic Profiling of African American Patients With Prostatic Adenocarcinoma Metastatic to the Lymph Nodes: A Pilot Study. Arch Pathol Lab Med. 2024;148(3):310-317.

Hissong E, Arora K, Andy C, Jessurun J, Yantiss RK. Histologic Manifestations of Gastrointestinal Adenovirus Infection After Stem Cell Transplant. Am J Surg Pathol. 2024.

Li Z, Zeng X, Shi B, Han J, Wu Z, Chen X, et al. Schnurri-3 controls osteogenic fate of Adipoq-lineage progenitors in bone marrow. J Orthop Translat. 2024;45:168-177.

Saunders KE, Gerken N, Khani F, Williamson SR, Wobker SE. Current gross examination and reporting patterns of post-neoadjuvant chemotherapy cystectomy specimens: Is it time for a standardized approach? Am J Clin Pathol. 2024.

Torres HM, Marino J, Simon MS, Singh HK, Westblade LF, Calfee DP. High touch surface bioburden associated with the use of disinfectants with and without continuously active disinfection in ambulatory care settings. Infect Control Hosp Epidemiol. 2024:1-3.

Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, et al. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. Eur Urol. 2024;85(4):361-372.